587 related articles for article (PubMed ID: 29529608)
1. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
Chen D; Liu J; Duan S; Chen P; Tang L; Zhang L; Feng Z; Cai G; Wu J; Chen X
Kidney Blood Press Res; 2018; 43(2):318-328. PubMed ID: 29529608
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathy.
Park KS; Han SH; Kie JH; Nam KH; Lee MJ; Lim BJ; Kwon YE; Kim YL; An SY; Kim CH; Doh FM; Koo HM; Oh HJ; Kang SW; Choi KH; Jeong HJ; Yoo TH
Hum Pathol; 2014 Feb; 45(2):236-43. PubMed ID: 24439222
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency may predict a poorer outcome of IgA nephropathy.
Li XH; Huang XP; Pan L; Wang CY; Qin J; Nong FW; Luo YZ; Wu Y; Huang YM; Peng X; Yang ZH; Liao YH
BMC Nephrol; 2016 Nov; 17(1):164. PubMed ID: 27806690
[TBL] [Abstract][Full Text] [Related]
4. The Oxford classification as a predictor of prognosis in patients with IgA nephropathy.
Kang SH; Choi SR; Park HS; Lee JY; Sun IO; Hwang HS; Chung BH; Park CW; Yang CW; Kim YS; Choi YJ; Choi BS
Nephrol Dial Transplant; 2012 Jan; 27(1):252-8. PubMed ID: 21606384
[TBL] [Abstract][Full Text] [Related]
5. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
Tian S; Yang X; Luo J; Guo H
Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria.
Tan M; Li W; Zou G; Zhang C; Fang J
Kidney Blood Press Res; 2015; 40(2):200-6. PubMed ID: 25924707
[TBL] [Abstract][Full Text] [Related]
8. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
9. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
Zittema D; van den Brand JA; Bakker SJ; Wetzels JF; Gansevoort RT
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i146-i153. PubMed ID: 28057871
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of IgA nephropathy patients with different proportions of crescents.
Zhang W; Zhou Q; Hong L; Chen W; Yang S; Yang Q; Chen W; Yu X
Medicine (Baltimore); 2017 Mar; 96(11):e6190. PubMed ID: 28296731
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH
J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358
[TBL] [Abstract][Full Text] [Related]
12. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
Riispere Ž; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
BMC Nephrol; 2017 Mar; 18(1):89. PubMed ID: 28292274
[TBL] [Abstract][Full Text] [Related]
13. Stratifying risk for progression in IgA nephropathy: how to predict the future?
Rafalska A; Franczuk J; Franczuk P; Augustyniak-Bartosik H; Krajewska M
Pol Arch Med Wewn; 2014; 124(7-8):365-72. PubMed ID: 24824600
[TBL] [Abstract][Full Text] [Related]
14. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
Park GY; Yu CH; Kim JS; Kang YJ; Kwon O; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
Korean J Intern Med; 2015 May; 30(3):345-53. PubMed ID: 25995665
[TBL] [Abstract][Full Text] [Related]
15. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.
Fabiano RCG; Araújo SA; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
J Pediatr (Rio J); 2017; 93(4):389-397. PubMed ID: 28130969
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
[TBL] [Abstract][Full Text] [Related]
17. Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria.
Komatsu H; Sato Y; Miyamoto T; Tamura M; Nakata T; Tomo T; Nishino T; Miyazaki M; Fujimoto S
Clin Exp Nephrol; 2016 Feb; 20(1):94-102. PubMed ID: 26123429
[TBL] [Abstract][Full Text] [Related]
18. Factors predicting progression of IgA nephropathies.
Coppo R; D'Amico G
J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
[TBL] [Abstract][Full Text] [Related]
19. To evaluate the utility of Oxford classification in predicting renal outcome in IgA nephropathy patients.
Saleem N; Nasir H; Anwar F; Aziz M; Khurshid K; Bashir S; Khan A
Int Urol Nephrol; 2024 Jan; 56(1):345-353. PubMed ID: 37378850
[TBL] [Abstract][Full Text] [Related]
20. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy.
Wang S; Dong L; Pei G; Jiang Z; Qin A; Tan J; Tang Y; Qin W
Front Immunol; 2021; 12():700224. PubMed ID: 34456912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
